Skip to main content
MMS logo

MMS · Maximus, Inc.

Track MMS — free
$52.65 -0.88 (-1.64%) At close · Oct 2
Market Cap
$2.75B
Shares
52.36M
Volume · Oct 2 610.06K Avg daily vol (3M) 642.91K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$52.65 Open$53.69 Day$52.61–53.69 52W close$52.10–98.93 Avg vol 30d648K Short int3.3M · 6.3% float · 5.8d Short vol57% Last earningsAug 6, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 5 wks
filed Aug 6, 2026
call held Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$5.25B
Trailing 12 months
Net income (TTM)
$370.89M
Trailing 12 months
Revenue growth YoY
-5.1%
Year over year
Operating margin
11.0%
Trailing 12 months
P / E (TTM)
8.0
Trailing earnings · reciprocal yield 12.6%
FCF yield
15.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-6.9%
Year over year · fewer shares
Price change (1Y)
-41.1%
Trailing year
Short interest
6.3%
Latest settlement · 5.8 days to cover
View all 115 metrics

AI Brief

Q3 FY26 earnings call · Aug 6, 2026
Q3 FY26

TL;DR. Maximus reported in-line Q3 revenue and margin gains but lowered FY2026 earnings, EBITDA margin, and free cash flow guidance due to a temporary customer-directed contractual modification on a major federal program (VA), while reiterating revenue guidance toward the low end.

Bullish
  • + Adjusted EBITDA margin expanded to 15.0% from 14.7% a year ago on AI/automation-driven efficiency gains.
  • + Signed contract awards and awarded-but-unsigned contracts both expanded, with unsigned awards up materially on longer-duration recompete wins.
  • + Defence and national security pipeline identified at nearly $47 billion, with notable wins at the Air Force and TSA.
  • + SNAP opportunity ramping with 40+ Accuracy Assistant demonstrations and FY25 national payment error rate of ~10.6% reinforcing demand for accuracy tools.
  • + AI initiatives are driving internal margin gains, with one 5-contract group achieving a 3.5% operating margin improvement.
Bearish
  • − FY2026 adjusted EPS guidance cut to $7.90–$8.20 and adjusted EBITDA margin to ~13.7% due to a temporary VA contractual modification.
  • − FY2026 free cash flow guidance lowered to $425–$475 million from prior expectations.
  • − VA incentive pause of ~180 days through December 31, 2026 reduces profitability; CFO signals Q4 13% implied EBITDA margin as a likely near-term run rate without those incentives.
  • − Federal civilian market seeing procurement delays, scope revisions and cancellations; book-to-bill at only ~0.5x on a trailing-12-month basis.
  • − Revenue declined 5.2% YoY to $1.28B and nine-month revenue fell ~4.4% to $3.93B, with FY26 revenue now expected toward the low end of the $5.2–$5.35B range.
  • − Q3 free cash flow was an outflow of $137 million and DSO remained elevated at 98 days, despite post-quarter collections of $245M.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −22%
below
Price vs 50-day avg −8%
below
RSI (14) 36
neutral
MACD trend Negative
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −10%
trailing
6-month return −22%
trailing
YTD return −39%
this year
Relative strength −34%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $57 › 200d $68 — 200d above 50d
Institutional flow Distributing
1 of 355 funds reported for Sep 30 · net -265 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
6.31% of float · ▲ +2.8% MoM · 5.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
355 holders — mid 3-yr range
Squeeze score 61
elevated · 0–100
Fundamentals
Strong
Revenue growth −2%
Y/Y
Gross margin 56%
expanding
EPS growth +10%
Y/Y
Free cash flow $330.4M
Valuation P/E 7.8
below peers
Buyback $400.0M
remaining
Balance sheet $1.1B
net debt
Quant / Vol
risk profile
High
Volatility 35%
annualized · 1-yr
Max drawdown −47%
past year
ATR 3.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 6 of last 6
Latest guidance · from the 8-K filed Aug 6, 2026
Revenue · fiscal year 2026 Initiated $5.2B – $5.35B
prior FY $5.43B midpoint −2.9% Y/Y
Adjusted diluted earnings per share · fiscal year 2026 Non-GAAP Initiated $7.90 – $8.20
Adjusted EBITDA margin · fiscal year 2026 Non-GAAP Initiated 13.7%
Free cash flow · fiscal year 2026 Non-GAAP Initiated $425M – $475M
Interest expense · fiscal year 2026 Initiated $88M
Tax rate · fiscal year 2026 Initiated 24% – 24.5%
U.S. Federal Services Segment operating margin · fiscal year 2026 Initiated 16.5% – 17%
U.S. Services Segment operating margin · fiscal year 2026 Initiated 9.5% – 10%
Guided vs delivered · last 6 settled
Revenue fiscal year 2024
guided $5.25B – $5.35B
$5.31B In line
Revenue fiscal year 2022
guided $4.4B – $4.6B
$4.63B Beat +2.9%
Revenue fiscal 2021
guided $3.4B – $3.53B
$4.25B Beat +22.9%
Diluted earnings per share fiscal 2021
guided $3.55 – $3.75
$4.67 Beat +27.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−22% Bearish
Price vs 50-day avg
−8% Bearish
RSI (14)
36 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $57 › 200d $68 — 200d above 50d
Institutional flow Distributing
1 of 355 funds reported for Sep 30 · net -265 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
6.31% of float · ▲ +2.8% MoM · 5.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
355 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $52 Now $53 · 1% Range high $99
vs 200-day avg -22% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture- non-GAAP $6.14 For the Nine Months Ended June 30, 2026 —
Adjusted EBITDA (Non-GAAP) non-GAAP 550.77M For the Nine Months Ended June 30, 2026 —
Adjusted EBITDA margin (Non-GAAP) non-GAAP 14% For the Nine Months Ended June 30, 2026 —
Adjusted net income excluding amortization of intangible assets and divestiture-related adjustme non-GAAP 332.92M For the Nine Months Ended June 30, 2026 —
Consolidated EBITDA (as defined by our Credit Agreement) non-GAAP $210.4M the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net income 103.59M
+23.88M Interest expense
-608K Other (income)/expense, net
+34.57M Provision for income taxes
+20.19M Amortization of intangibles
+7.36M Stock compensation expense
+0K Capitalized software impairment charges
-1.16M Divestiture-related (gains)/charges, net
+11.87M Depreciation and amortization of property, equipment, and capitalized software
+10.72M Pro forma and other adjustments permitted by our Credit Agreement
= Consolidated EBITDA (as defined by our Credit Agreement) 210.4M
Contracts pending (awarded but unsigned) $1.35B the third quarter of fiscal year 2026 —
DSO 98 the third quarter of fiscal year 2026 —
Free cash flow (Non-GAAP) non-GAAP -208.62M For the Nine Months Ended June 30, 2026 —
Signed contract awards (year-to-date) $1.25B the third quarter of fiscal year 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Business Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MMS
Maximus, Inc.
this stock
$2.75B -39.0% -2.4% 7.8 6.3%
CTAS
Cintas Corp
$78.56B +2.6% +6.4% 40.0 2.8%
RELX
Relx PLC
$58.28B -17.3% — — 0.4%
TRI
Thomson Reuters Corp /Can/
$42.89B -26.0% — — 2.9%
CPRT
Copart Inc
$25.27B -30.5% +24.7% 17.6 3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
355
% held
106.3%
Reported
1 of 355
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
437
View
Short & Settlement
Short Interest Rising
Shares short
3.3M
Days to cover
5.8d
Change
+91.3K sh
View
Short Volume
Short vol %
57%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
455
Value
$25.9K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
38.7%
Week of
Aug 24, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$5.4B
Net income (FY)
$319.0M
EPS diluted
$5.51
View
Buybacks
Authorized
$400.0M
Remaining
$400.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 6, 2026
This year
9
View
Proposed Sales
Value
$174.0K
Shares
3.2K
Filed
Oct 1, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 6, 2026
View

Performance

5D 20D 120D MTD YTD
MMS +0.1% -9.9% -21.8% -1.0% -39.0%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY +0.3% -9.4% -34.0% -1.9% -51.9%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$400.00M
Spent (derived)
$0
Remaining
$400.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1032220 CUSIP 577933104 13F (30d) 7 filings 7 filers Visit website Investor relations